Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 November 2024 | Story Leonie Bolleurs | Photo Stephen Collett
SARIMA - 2024
The Directorate Research Development at the university proudly participates in the SARIMA Visibility Project, aimed at enhancing its global visibility and research excellence.

The University of the Free State (UFS) has been selected to participate in a high-impact initiative managed and coordinated by the Southern African Research and Innovation Management Association (SARIMA). The SARIMA Visibility Project, which focuses on elevating institutional prominence, aims to enhance the university’s global visibility and strengthen its capacity to secure international grants. By participating in this initiative, the UFS is positioning the Directorate for Research and Development (DRD) to benchmark against other leading Tier 1 institutions, adopting best practices in research management and innovation to fuel future growth.

Key outcomes already underway

Since joining the initiative, the university has implemented several key interventions. Most notably, the development and execution of standardised operating procedures have been introduced. These procedures ensure alignment with global standards, creating consistency across various functions within DRD. Such efforts not only improve operational efficiency, but also boost the university’s competitiveness in attracting international research collaborations and securing funding opportunities. Other platforms to promote visibility that the DRD has adopted this year include its newsletter, Research Nexus, webinars, and a presence on social media.

The SARIMA Visibility Project at the UFS is spearheaded by the DRD under the leadership of Dr Glen Taylor. As pioneers of the initiative, the DRD team is working closely with SARIMA to ensure the successful implementation of key strategies aimed at improving the research infrastructure and elevating the university’s global standing. Their leadership has been instrumental in driving efforts to meet the project's ambitious objectives. These objectives include promoting best practices in research and innovation management across the region. They aim to support the research and innovation ecosystem to drive regional social and economic development. Additionally, the project seeks to engage key stakeholders to strengthen collaboration. Another objective is to building capacity among research and innovation management practitioners through training and development initiatives.

The SARIMA project is closely aligned with the UFS’s Vision 130, a strategic roadmap designed to propel the institution into its 130th anniversary in 2034. Vision 130 seeks to elevate the university’s academic and research standing on the global stage. By enhancing international partnerships and refining research management practices, SARIMA is playing an important role in supporting the university in its goal of becoming a globally recognised research institution, in line with Vision 130.

Value added to the research environment

In the few months since its launch, the SARIMA initiative has already added significant value to the UFS Research Office. The introduction of standardised procedures has not only improved consistency across departments, but has also made the office more agile and responsive to the demands of international collaborations. Benchmarking exercises conducted as part of the project have allowed the university to identify key areas for improvement, adopting innovative solutions that further enhance the institution’s research capacity and global visibility.

The SARIMA Visibility Project marks a significant step forward for the university. It is not only a means of raising the institution’s profile, but also a platform for long-term sustainable research excellence. As the UFS continues to benefit from this initiative, it is setting the stage for a future of global recognition and academic achievement that will benefit both the institution and the broader academic community for years to come.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept